Cargando…
Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?
Nasopharyngeal carcinoma (NPC) is distinct in its anatomic location and biology from other epithelial head and neck cancer (HNC). There are 3 WHO subtypes, which considers the presence of Epstein-Barr virus (EBV) and other histopathology features. Despite the survival benefit obtained from modern tr...
Autores principales: | Juarez-Vignon Whaley, Juan Jose, Afkhami, Michelle, Onyshchenko, Mykola, Massarelli, Erminia, Sampath, Sagus, Amini, Arya, Bell, Diana, Villaflor, Victoria M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477128/ https://www.ncbi.nlm.nih.gov/pubmed/37318724 http://dx.doi.org/10.1007/s11864-023-01101-3 |
Ejemplares similares
-
Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going?
por: Juarez-Vignon Whaley, Juan Jose, et al.
Publicado: (2023) -
Prolonged response to checkpoint inhibitor therapy in two metastatic mucoepidermoid salivary gland carcinoma cases: a research report
por: Pharaon, Rebecca R., et al.
Publicado: (2022) -
Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023) -
Animal Sentience: Where are We and Where are We Heading?
por: Proctor, Helen
Publicado: (2012) -
Research Integrity: Where We Are and Where We Are Heading
por: Zhaksylyk, Alikhan, et al.
Publicado: (2023)